|
  Matthew J. Mimiaga, ScD, MPH, is an Assistant Professor at Harvard Medical School and an affiliated investigator at The Fenway Institute, Fenway Health. He completed his Post-Doc training in Behavioral Medicine at Harvard Medical School/Massachusetts General Hospital and received his Doctorate from Harvard School of Public Health, majoring in Psychiatric Epidemiology, with minors in Infectious/Chronic Disease Epidemiology and Biostatistics, and was awarded the Harvard University Presidential Scholarship. He has co-authored more than 90 articles, chapters and other publications on HIV/AIDS and related infectious disease topics and was recently awarded a grant from NIDA to test a behavioral treatment for crystal methamphetamine addiction in HIV-uninfected MSM. Dr. Mimiaga is the PI of two Harvard CFAR grants – the first is to develop and implement a behavioral intervention to improve medication adherence among HIV-infected adolescents, and the second is to develop and implement a combined contingency management and behavioral activation therapy intervention aimed at HIV-infected individuals who are engaged in HIV care and are currently dependent on crack, cocaine, or methamphetamine. Dr. Mimiaga is also the PI on two MA Department of Public Health funded studies. The first is examining the social and sexual network characteristics and associated HIV risks of Black/African American MSM; the second is assessing how sexual environments (such as sex parties, bars/night clubs, and the Internet) impact sexual risk-behaviors among MSM. These projects are collecting information to determine the best potential for HIV-prevention interventions with these high-risk subpopulations of MSM. Dr. Mimiaga is the co-PI (PI: Dr. Kenneth Mayer) on a Gilead funded project to assess Massachusetts’ physicians’ attitudes, knowledge and beliefs regarding pre-exposure prophylaxis (PrEP) as a biomedical intervention to prevent HIV transmission. In addition, he is currently a member of the protocol development team and co-investigator for HPTN 063 (PI: Dr. Steven Safren) – a proposal to develop international prevention trials for HIV-infected individuals in care settings in Zambia, Thailand, and Brazil. Dr. Mimiaga is a co-investigator on two NIH funded R21s related to HIV prevention among MSM in India. The first is to understand the social and sexual networks of MSM who are married to women in Mumbai (PI: Dr. Kenneth Mayer) as this group has been identified as an important “bridge” population to transmitting HIV to their wives and unborn children. The second is to understand the impact of HIV stigma, discrimination, intimate partner violence and/or history of abuse or trauma on risk behavior and the rates of co-occurring mental illness and drug or alcohol abuse among MSM in Chennai, and then to develop and pilot test a randomized controlled culturally responsive intervention among this at risk population (PI: Dr. Steven Safren). Finally, Dr. Mimiaga is the co-principal investigator on a Harvard Catalyst grant (PI: Dr. Donn Colby) examining the HIV prevalence and associated risk behaviors of male sex workers in Ho Chi Minh City, Vietnam. Dr. Mimiaga is actively involved with teaching seminars to Post-Doctoral Fellows in the Behavioral Medicine and Adult CBT tracks in the Department of Psychiatry at Harvard Medical School, and is currently teaching within the Epidemiology Department at Harvard School of Public Health: EPI 220 is an applied, mid-level course in the psychiatric epidemiology track. His course focuses on interview schedules designed to diagnose psychiatric disorders in clinical settings, household surveys and behavioral research. His main research interests include HIV/AIDS, sexual minority health, mental health and substance use disorders, psychiatric and infectious disease epidemiology, and global health.
Complete Curriculum Vitae
|
